Karyopharm Therapeutics (KPTI) said Monday it will implement a 1-for-15 reverse stock split, effective at 5 pm ET on Tuesday.
The company said one of the main goals of the reverse stock split is to raise the per-share price of its common stock to enable it to regain compliance with Nasdaq's minimum bid price rule.
Karyopharm said its shares are expected to start trading on a split-adjusted basis when markets open on Wednesday.
The company's shares were down over 3% in recent trading.
Price: 0.58, Change: -0.02, Percent Change: -3.07
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。